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Despite innovations in HIV counseling and testing (HCT), important gaps remain in understanding
linkage to care. We followed a cohort diagnosed with HIV through a community-based HCT
campaign that trained persons living with HIV/AIDS (PLHA) as navigators. Individual,
interpersonal, and institutional predictors of linkage were assessed using survival analysis of self-
reported time to enrollment. Of 483 persons consenting to follow-up, 305 (63.2%) enrolled in HIV
care within 3 months. Proportions linking to care were similar across sexes, barring a sub-sample
of men aged 18–25 years who were highly unlikely to enroll. Men were more likely to enroll if
they had disclosed to their spouse, and women if they had disclosed to family. Women who
anticipated violence or relationship breakup were less likely to link to care. Enrollment rates were
significantly higher among participants receiving a PLHA visit, suggesting that a navigator
approach may improve linkage from community-based HCT campaigns.
Keywords
Linkage to care; Antiretroviral treatment; Community-based testing; HIV-1; Sub-Saharan Africa;
Survival analysis; HIV counseling and testing
The advent of antiretroviral therapy (ART) has increased quality of life and life expectancy
for persons living with HIV/AIDS (PLHA) [1–3]. However, those in resource-constrained
settings tend to start ART treatment with more advanced disease than those in resource-rich
settings [4]. Late diagnosis is associated with HIV-related morbidity and mortality in sub-
Saharan Africa [5], as are late presentation into care [6] and delayed ART initiation [5, 7–
16]. Delays in diagnosis, linkage to care, and subsequent ART initiation also pose a higher
risk of HIV transmission to others, since treatment reduces viral load and infectivity [17–
21].
Understanding the dynamics of linkage to care in sub-Saharan Africa is particularly salient
amidst recent calls for universal HIV testing and immediate treatment [22]. In alignment
with a ‘test and treat’ approach, new strategies for HIV counseling and testing (HCT), such
as community-based testing via mobile clinics, have proven to be cost-effective and
successful at reaching previously untested individuals [23–28]. At the same time, these
innovative testing strategies may increase the challenges of linking individuals to the
healthcare facility to receive care and treatment [29].
Much of the research around linkage to care has occurred in resource-rich settings, such as
the United States and Europe, where delayed uptake of care is associated with long wait
times for initial appointments [30], testing for the first time [19, 31], rural residence [32], or
being diagnosed at an early stage of disease while still feeling well [33]. Few sub-Saharan
Africa programs routinely assess the proportion of HIV-diagnosed patients who successfully
link to care or treatment. Those that have measured linkage achieve strikingly poor results:
between 30–62% of persons receiving HIV positive test results successfully link to care [34–
39]. A recent systematic review estimates that if studies were to track patients from HIV
testing to CD4 count results, clinic enrollment, and initiation of ART, between 17–33% of
patients would complete all three linkage steps [40]. The dearth of studies identified by the
systematic review highlights the urgent need for better research on linkage to care.
Of the few recent studies that examine linkage to care in sub-Saharan Africa, only one [39]
has studied linkage from community-based HCT. This gap in the literature is crucial to fill,
because a significant portion of HIV testing in the coming years will likely be community-
and home-based strategies, particularly in light of recent findings that community-based
HCT detects almost four times more HIV cases than standard clinic-based testing [41].
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All existing studies, to our knowledge, examine clinical and demographic predictors of
linkage. However, in resource-constrained settings, issues beyond demographics are likely
to shape linkage. For example, research shows that broader gender dynamics [35, 42],
entrenched poverty [43–45], and HIV-related stigma [46–49] inhibit uptake of HIV care and
treatment, even as ART has become more available. This research adds to the knowledge
base by exploring the interpersonal and institutional factors that determine linkage to care.
Methods
This paper presents a cross-sectional study of linkage to care following a community-based
HCT campaign conducted in Nyanza Province, Kenya during August–September, 2009.
Described fully elsewhere [26], the Integrated Prevention Demonstration (IPD) model
combines community-based HIV testing with distribution of long-lasting insecticidal nets
and point-of-use water purifiers, and was implemented by Vestergaard Frandsen in
partnership with the Kenyan Ministry of Health. During the three-day campaigns, mobile
tents were established in six community sites outside Kisumu, an urban center, and near
Kisii, a hillside town.
HCT was offered in accordance with the Kenyan national guidelines and adhered to key
principles of informed consent, confidentiality and privacy. Each client was registered and
given a unique client number delinked from identifiers. A nationally certified HCT
counselor provided individual pre-test counseling and obtained verbal informed consent.
Finger prick blood samples were screened for HIV infection using serial rapid ELISA
testing, as per national guidelines [50].
Clients testing HIV positive were provided with a referral to care and were offered a rapid
CD4 count using Guava AutoCD4 system (Guava technologies, Massachusetts, USA). In
most cases, patients received their CD4 count results within 3 h, with about 30% of the
population asked to return the following day for results. Newly diagnosed clients were also
invited to receive a follow-up home visit by a trained PLHA navigator. Those who
consented were guided through completion of the locator form. Following the campaign,
PLHA navigators attempted to conduct home visits with all persons providing locator
information, in order to offer support for enrolling into HIV care.
Data Collection
Data presented here were collected by a separate team of trained researchers who conducted
follow-up interviews 10 months after the HCT campaign. These interviews were separate
from the home visits conducted by PLHA navigators, but relied on the same locator form
information collected at the campaign by consenting participants. To conduct the 10-month
follow-up interview, researchers liaised with PHLA navigators to invite eligible clients to
participate via personal visit or cell phone. The researchers then used locator information to
trace and consent interested clients. Individuals were eligible for our study if they were more
than 18 years of age, had tested positive during the HCT campaign, were not previously
enrolled in HIV care or treatment at the time of HCT campaign, and consented to be traced
at their home. Persons who were not located successfully at the first visit received one
additional visit by research staff.
Measurements
There were two primary outcomes for this study. The first outcome, linkage to care, was
based on participant self-report of clinic enrollment up to the time of interview 10 months
after the HCT campaign (Y/N). The second outcome, time to linkage, was measured in
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months from the first day of the month diagnosed at the HCT campaign (August or
September) to the first day of the month participants reported that they enrolled in care.
Based on an extensive review of the literature, we used a social-ecological framework [51–
53] to identify covariates of linkage to care at individual, interpersonal, and institutional
levels. At the individual level, a number of socio-demographics were collected (sex, age,
education, ethnicity, religion, marital status, and occupation). Health status was measured
using one item from the SF-36 health survey that is highly predictive of many health
behaviors and outcomes: “In general, would you say your health is excellent, good, fair or
poor?” [54]. To measure mental health, we used the PHQ-9 clinical depression scale, a
measure that has been validated in Kenya [55] and has internal consistency in this sample
(Cronbach alpha (α) = 0.86). Substance use was measured through self-report of frequency
of alcohol and drug use.
At the interpersonal level, we assessed PLHA Navigator home visits by asking whether the
client received a home visit and number of visits received. We asked clients about disclosure
of HIV status to friends, family, or healthcare workers. To understand gender dynamics, we
used three items from the power in relationships scale concerning household decision-
making [56]. We measured participant perceptions of HIV-related stigma using measures
that have been validated and used in the study setting [57]. Anticipated stigma (α = 0.78)
was measured using a 9-item scale of a person’s anticipation of experiencing stigma because
of enrolling in HIV care [58] Community stigma (α = 0.84) was measured using the mean of
7 items from the ‘perceived discrimination’ sub-scale of a measure developed by NIMH
Project Accept [59]. Self-stigma (α = 0.80) was measured using the ‘self-stigma’ sub-scale
from the HASI-P stigma instrument [60]. Consistent with other studies in HIV-positive
populations [61], we asked about three dimensions of social support: (1) having a
confidante; (2) having people to depend on (social network); (3) having instrumental support
(financial help, a place to stay, or assistance visiting the doctor). Social support variables
were converted to binary (agree vs. disagree) for analysis.
At the institutional level, we asked questions about the logistics of linkage to care.
Transportation was assessed by asking the distance (in kilometers), time (in minutes), and
cost (in Kenya shillings) of travel by public transportation to the clinic. Associated costs
were explored by asking the total amount spent monthly (in Kenya shillings) on medication,
clinic costs, or missed income [62]. Questions around knowledge of ART and ART
availability were drawn from the Kenyan ARTIS study [63] and those who responded “don’t
know” to these items were considered to have uncertainty around ART knowledge/
availability. Participants were asked about the type of ART medications they used, if any,
and these were listed by prompting participants to gather the medication bottles and show
them to the researcher.
Statistical Analysis
All analyses are presented separately for men and women, as we hypothesized that the
factors associated with enrollment into care would differ by sex. We compared descriptive
characteristics of men and women using χ2 tests for categorical variables. Bivariate analyses
assessed differences in time to enrollment for each predictor variable using Cox proportional
hazard models for time-to-event data with censoring. Variables were selected for inclusion
in bivariate analysis provided there was enough variability in responses (>5%/binary
response option) separately among male and female respondents. For inclusion in the
multivariate model, variables had to be associated with linkage to care (P < 0.10) in the
bivariate Cox regression models. All models accounted for the clustering of data within site.
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Cox regression assumes that each predictor has an equal effect throughout the time of
observation. We observed several violations of this assumption in bivariate analyses. We
created interaction terms between predictors and the natural log of time to enrollment to
address violations in multivariate models. Final models did not violate the proportionality
assumption. All statistical analyses were performed using Stata 10.0 for Windows
(StataCorp, Texas).
Ethical Review
Ethical approval was obtained from the Kenya Medical Research Institute Ethical Review
Committee (SSC#1776) and the University of California, San Francisco Committee on
Human Research (CHR#10035623).
Results
Out of 10,203 persons tested in the community-based HCT campaign, 808 persons were
over 18 years of age, tested HIV-positive during the HCT campaign, and were not already
enrolled in HIV care at time of HIV testing. A total of 702 (86.8%) HIV-infected persons
had a CD4 test conducted, among whom 603 (85.9%) had CD4 counts above 250 cells/μl
(89.4% of women and 75% of men; Pearson χ2 = 18.59 for high CD4 by sex, P < 0.001).
Of the eligible population, 684 (85%) provided locator information. A total of 547 (80.0%)
were located 10 months later at time of follow-up interview. Of those who were traced, a
total of 158 clients in Kisii consented to the interview (7.6% refusal rate), as did 342 in
Kisumu (9.0% refusal rate). Of the 500 completed surveys, 17 individuals were
subsequently excluded from analysis as they reported that they enrolled in care prior to
testing HIV-positive at the IPD campaign.
Similar to the overall population of campaign attendees, the 483 individuals in our study
constituted a sample (Table 1) with more women than men (73.7 vs. 26.3%) and more
residents of Kisumu than Kisii (68.7 vs. 31.3%). Less than one-third were educated beyond
primary school, though two-thirds could read a local language newspaper. Two-thirds of
respondents owned either a cell phone or a radio (half had both). Although many
characteristics were similar across sexes, women were more likely to be widowed, to have
no formal education, and to state housework as their primary occupation than men. While
less than 10% of men reported being polygamous, nearly 30% of women reported that they
were married to a polygamous man.
Cumulative linkage to HIV care and treatment was high: 63.2% enrolled within 3 months of
the campaign; 81.4% enrolled by time of follow-up interview 10 months later (83.4% of
women and 75.6% of men; Pearson χ2 = 3.79 for linkage by sex, P = 0.052). Median time to
enrollment was one month and interquartile range was 0–6 months. A total of 72 men
(56.7%) and 217 women (61.0%) received PLHA visits during the 10-month period. Neither
proportion nor frequency of PLHA visits differed significantly between men and women.
The Kaplan–Meier survival curves (Fig. 1) illustrate the significant relationship over time
between receiving a PLHA navigator visit and linkage to care for men and women. In
bivariate analysis, factors significantly associated with time to linkage (Table 2) for both
men and women included: older age, being widowed, greater knowledge around ART,
disclosure to family, and receiving a PLHA navigator home visit. For men, additional
factors were occupation, marital status, alcohol use, self-stigma, disclosure to spouse, and
having a confidante. For women, additional factors were education, physical health,
occupation, and anticipating a negative reaction from a partner in the form of relationship
breakup or physical violence.
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For several variables analyzed, the association with linkage to care was not consistent over
time. Much of this effect in men was due to a subset of men (aged 18–25 years) who were
unlikely to enroll in care. Only 2 of 14 (14.3%) young men linked to care, and differed from
the larger sample in several ways: they were more likely to be single (66.7 vs. 3.5% of older
men) and use alcohol (78.6 vs. 33.6%), and less likely to disclose their HIV status (14.3 vs.
84.1%). Because of these differences, the subsequent multivariate survival analysis was
restricted to men over 25 years of age (n = 104).
Multivariate analyses for men and women produced adjusted associations of predictors of
linkage to care (Table 3). The model for men included all eligible males over 25 years with
complete data (80.3% of total sample, 92.0% of men over 25 years). The multivariate model
suggests that greater age was associated with higher likelihood of linkage to care, while
uncertainty around ART knowledge was associated with lower likelihood. Higher perceived
discrimination was associated with a higher rate of linkage over time. Disclosure of HIV
status to spouse was associated with higher likelihood of linkage. This association increased
over time, as indicated by the interaction term, to 2.41 at 5 months (95% CI 1.74–3.35), and
2.83 at 10 months (95% CI 1.77–4.52). As with the unadjusted Kaplan–Meier curves,
receiving a PLHA visit remained associated with linkage in the multivariate model, and the
association likewise increased over time to 1.77 at 5 months (95% CI 1.47–2.13) and 1.99 at
10 months (95% CI 1.52–2.60).
The multivariate model for women included all women with complete data (82.3% of total
sample). The model suggests greater education, being older, and being widowed/single were
associated with higher rates of linkage per month, while lack of HIV knowledge was
associated with lower rates. Women who anticipated a negative response from their partner,
in the form of breakup or violence, were less likely to link to care. Similar to men, receiving
a PLHA visit was associated with a higher rate of linkage among women. Women who had
disclosed to family had rates of linkage that were 1.33 (95% CI 1.10–1.61), 1.47 (95% CI
1.38–1.58), and 1.54 (95% CI 1.40–1.70) times as high as non-disclosers at 1, 5, and 10
months, respectively. The association between better health and enrolling in care
strengthened over time to 5 months (AHR = 1.62; 95% CI 1.55–1.69) and 10 months (AHR
= 1.71; 95% CI 1.60–1.82). There was also a positive association between travel time to a
clinic of choice and enrollment (AHR = 1.26; 95% CI 1.04–1.54), meaning women who
reported a farther distance to the clinic were more likely to enroll over time.
Discussion
The cumulative proportions of patients in our sample linked to care by three months (63.2%)
and by the time of the interview (81.4%) were high, matching linkage rates of cohorts in
resource-rich settings [29]. One challenge of mobile testing is that it targets people at an
earlier stage of HIV infection [64–67], potentially inhibiting linkage for those who wait for
signs of illness to emerge before seeking care [68–70]. Though selection bias in our study
may have played a role, the high enrollment rates suggest that aspects of the HCT campaign
were successful in encouraging linkage even among early-diagnosis patients.
At the time of the HIV testing campaign, Kenyan National Guidelines recommended ART
for patients with a CD4 count <250 cells/μl (current guidelines use a cutoff of <350 cells/
μl). Knowledge of a low CD4 count may have motivated patients to go earlier for HIV care
than patients with higher CD4 counts. Since we were unable to link CD4 testing data to
follow-up interviews, we cannot ascertain precisely how CD4 counts influenced time to
linkage in our sample. This will be an essential component of future studies on linkage to
care as ART is scaled-up.
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Home visits by PLHA navigators seem to be a successful linkage strategy in sub-Saharan
Africa, where research has already shown that lay community health workers (CHW) can
increase HIV testing uptake [71], reduce linkage delays [64], improve ART adherence [72,
73], and improve clinical indicators such as CD4 cell count [74]. Called a ‘navigation
model’, similar methods are being employed widely in the United States [75–77]. The
PLHA navigator strategy deserves further attention to HIV care and treatment programs in
resource-constrained settings.
Contrary to some studies [6, 7, 78, 79], but aligned with others [39], older clients in our
sample were more likely to link to care each month. In particular, young men were highly
unlikely to ever enroll in care, and exhibited a range of traits (single marital status, low
disclosure, higher prevalence of alcohol use) that differed strongly from the rest of the men
interviewed. Though it is difficult to generalize from this small sample of young men (n =
14), this study suggests that PLHA visits were not a successful strategy for this group and
that alternative approaches should be considered for recruiting young, HIV-positive men
into care. This finding is consistent with other studies that suggest men enroll at a slower
rate than female counterparts [42, 79]. However, studies in Kenya have found healthcare
utilization around HIV testing and treatment of sexually transmitted infections slower
amongst women than male counterparts [80–82]. These discrepancies underscore the
importance of disaggregating data by sex and age in future studies on uptake of HIV care.
Similar to other studies [78, 83–85], women with less formal education were less likely to
link to care, as were both men and women with less HIV knowledge. Lack of information
about ART is associated with delayed care [49], high-risk HIV sexual behaviors among both
men and women [86], and HIV seroprevalence among women [63]. It may be challenging
for newly diagnosed clients to take in nuanced information about ART treatment at the time
of HIV testing [87–89]. Employing CHWs or PHLA navigators to distill information,
answer questions, and support treatment literacy following HIV testing may address the
information gap.
Women were less likely to link to care over time when they anticipated a negative partner
reaction, in the form of intimate partner violence or breakup of a relationship. Disclosure
was associated with greater linkage among both men and women, although for men the main
association derived from disclosure to a spouse, while for women it was disclosure to
family. Non-disclosure to partners has been recognized as an impediment to enrollment in
other studies in Africa, in terms of timely presentation to HIV care [79], initiation of ART
[35, 46], and treatment adherence [90]. Women, in particular, often choose not to disclose
their HIV status for fear their male partner will react with abuse or abandonment [91–95],
and partner disclosure has been shown to lead to a loss of economic support, blame, stigma,
and violence [96–99].
As in other sub-Saharan African settings [46, 47, 68, 100–103], HIV-related stigma shaped
decisions regarding uptake of care and treatment. The surprising finding that higher
perceived discrimination was associated with higher rates of enrollment among men could
be a result of men encountering additional discrimination following the decision to enroll, or
could have resulted from other unmeasured associations. Likewise, we found that longer
travel time was associated with higher rates of enrollment into care among women—perhaps
a consequence of the fact that the greater the distance to a facility, the less likely a client was
to risk a potentially stigmatizing encounter with a neighbor or relative. Distance and
transportation costs associated with accessing care have been shown to be a determinant of
healthcare utilization in other studies [46, 48, 104]. Findings from this study suggest that
motivation to engage in care may overcome logistical barriers, at least at the beginning of
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care and treatment, but it is unclear whether this remains the case as individuals confront the
cost of care over time.
Study Limitations
Findings from our study should be reviewed in light of study design limitations. We
followed HIV-positive persons prospectively from time of diagnosis, but had access to only
a minimal amount of data collected by the HCT campaign at the time of testing. The lack of
exact date of diagnoses and enrollment decreased the precision of our measure of time to
enrollment. Many individuals testing HIV-positive at the campaign did not participate in the
study because they were ineligible (e.g. already on ART), were untraceable (e.g. chose not
to provide locator information), or refused the interview. The latter two subsets may be at
particular risk of not linking to care, since stigma or other social factors may have caused
them to decline the opportunity to be followed at home. This sampling bias may
overestimate enrollment rates and potentially underestimate the extent to which the various
social and interpersonal predictors inhibited enrollment.
The data reported here are comprised of follow-up interviews conducted 10 months after
testing, when clients may have had difficulty recalling their exact date of linkage to care. We
were unable to systematically triangulate findings from our data with clinic enrollment data.
Social desirability bias may have influenced self-reports on the part of clients. In addition,
the retrospective nature of data collection makes it difficult to ascertain the direction of
causality for the associations observed. Because this study took place within a single cohort
in two sites, the findings may not be generalizable to other settings.
Recommendations
There is an urgent need to better understand the reasons for delays in linkage to care,
particularly in sub-Saharan Africa, where only a select few studies have examined linkage
from HIV testing to clinic enrollment [64, 105–107]. The social-ecological approach used in
this study may provide a useful theoretical framework for future research and interventions.
In exploring social-ecological drivers of linkage, we found that interpersonal dynamics
strongly informed time to linkage for both men and women. In future studies, interpersonal
issues such as spousal disclosure, fear of relationship break-up or violence, and access to
social support should be included. We posit that expanding beyond individual level clinical
characteristics in HIV linkage research will be a necessary step for designing effective
interventions.
High enrollment rates among our sample suggest that a ‘navigator model’ may be supportive
of early linkage to care following community-based HCT campaigns. The population
attending this HCT campaign had relatively high CD4 counts, suggesting that this HCT
approach could be used to identify PLHA earlier in disease progression. Significant gains in
prevention of morbidity and vertical transmission can be expected when patients initiate
ART earlier [108], highlighting the urgent need for interventions, like the navigator model,
that speed linkage to care.
Beyond the navigator model, two further recommendations should be considered by future
programs. First, partner dynamics should form a central part of future HIV testing
campaigns, especially since less than 10% of PLHA globally know the HIV status of their
partners [109]. Couple-centered testing is a promising strategy for improving disclosure to
partners [110] and increasing uptake of HIV treatment [111]. At a minimum, HIV testing
campaigns should address real concerns about HIV status disclosure, risk of intimate partner
violence, and social support. Second, campaigns need to build strategies for reaching and
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linking young, single individuals to HIV care, since these are populations that may be at
greatest risk of transmitting HIV and are least likely to enroll in care.
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Fig. 1.
Time to linkage following HIV testing for those receiving and not receiving a PLHA
navigator home visit, by sex
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Table 1
Respondent characteristics compared by sex
Characteristic Men Women
Number Valid percent Number Valid percent
Sex (n = 483) 127 356
Age (n = 463)†
 25 and under 14 11.2 75 22.2
 26–35 41 32.8 146 43.2
 36–45 45 36.0 81 24.0
 46 and over 25 20.0 36 10.7
Marital status
 Ever married (n = 478) 116 91.3 334 95.2
Current marital status (n = 475)†
 Single 12 9.6 27 7.7
 Married/partnered 99 79.2 217 62.0
 Separated 6 4.8 24 6.9
 Widowed 8 6.4 82 23.4
Polygamy: men with multiple wives, women whose husbands have multiple wives
(n = 478)†
11 8.6 100 28.5
Have children with current partner (n = 479) 104 81.9 263 74.7
Ethnic group (n = 480)
 Luo 85 67.5 242 68.4
 Kikuyu 0 0.0 1 0.3
 Kisii 40 31.8 108 30.5
 Luhya 1 0.8 3 0.9
District (n = 483)
 Kisumu 87 68.5 245 68.8
 Kisii 40 31.5 111 31.2
Education status (n = 481)†
 Never attended school 0 0.0 22 6.2
 Primary school 82 65.1 250 70.4
 Secondary school 29 23.0 68 19.2
 Post-primary/Vocational 12 9.5 9 2.5
 College/University 3 2.4 6 1.7
Local language reading (n = 458)*
 Not at all 6 4.9 24 7.1
 Can read with difficulty 22 18.0 94 28.0
 Can read easily 94 77.0 218 64.9
Religion (n = 245)a
 African independent churches 28 45.9 71 38.6
 Protestant 11 18.0 49 26.6
 Roman catholic 15 24.6 39 21.2
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Characteristic Men Women
Number Valid percent Number Valid percent
 Other 7 11.5 25 13.6
Type of employment (n = 467)b
 Housework† 1 0.8 52 15.3
 Selling things† 16 12.7 111 32.6
 Farming or horticulture 44 34.9 149 43.7
 Manual labor† 32 25.4 24 7.0
 Fishing† 4 3.2 1 0.3
 Teacher or health worker 1 0.8 6 1.8
 Driver† 8 6.4 0 0.0
 Other† 33 26.2 25 7.3
*P < 0.05 for test of hypothesis that male and female subgroups are from the same population (χ2 tests)
†P < 0.01 for test of hypothesis that male and female subgroups are from the same population (χ2 tests)
a
Response rates to this question were low because original list of possible religions was not accurate
b
Employment percentages do not add to 100% across categories because multiple responses permitted
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Table 3
Multivariate associations among demographics, health status, social factors, PLHA visits, and time to linkage
among men (> 25 years) and women
AHRa (95% CI) Z P value
A: Multivariate Cox regression for men over 25 years (n = 104)
Age (standardized values) 1.30 (1.09–1.55) 2.97 0.003
Education greater than primary school 0.86 (0.55–1.33) −0.69 0.487
Uncertainty around ART knowledge 0.23 (0.10–0.54) −3.39 0.001
Perceived discrimination 1.29 (1.11–1.51) 3.22 0.001
Disclosure to spouse 1.67 (1.07–2.61) 2.24 0.025
 Interaction of disclosure and time 1.26 (1.03–1.54) 2.21 0.027
PLHA visit 1.35 (0.97–1.87) 1.81 0.071
 Interaction of PLHA visit and time 1.18 (1.05–1.33) 2.86 0.004
AHR (95% CI)b Z P value
B: Multivariate Cox regression for women (n = 293)
Age (standardized values) 1.08 (1.05–1.15) 4.98 <0.001
Education above primary school 1.54 (1.11–2.14) 2.58 0.010
Uncertainty around ART knowledge 0.36 (0.19–0.70) −3.04 0.002
Health status of good or excellent 1.43 (1.19–1.72) 3.82 <0.001
 Interaction of health status and time 1.08 (1.05–1.11) 5.46 <0.001
Marital status: widowed or separated 1.36 (1.19–1.56) 4.53 <0.001
Anticipated negative partner response (break-up or intimate partner violence) 0.64 (0.51–0.79) −4.08 <0.001
Disclosure to family 1.33 (1.10–1.61) 2.89 0.004
 Interaction of disclosure and time 1.07 (1.02–1.12) 3.00 0.003
Distance to HIV care facility (in hours) 1.26 (1.04–1.54) 2.32 0.021
PLHA visit 1.20 (1.00–1.43) 1.99 0.047
aAHR adjusted hazard ratio, CI confidence interval. Schöenfeld test for final model for men = 2.12; degree of freedom = 5; P = 0.833
b
In addition to variables listed, model is adjusted for missingness in anticipated partner response. Schöenfeld test for final model for women =
3.92; degree of freedom = 5; P = 0.561
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